Literature DB >> 21481991

HIF-1α inhibitors: synthesis and biological evaluation of novel moracin O and P analogues.

Yan Xia1, Yinglan Jin, Navneet Kaur, Yongseok Choi, Kyeong Lee.   

Abstract

The natural products moracins O and P exhibited potent in vitro inhibitory activity against hypoxia-inducible factor (HIF-1), which is a key mediator during adaptation of cancer cells to tumour hypoxia. Systematic variations of the structures of benzofuran type moracins were made and structure-activity relationship analysis showed the importance of the 2-arylbenzofuran ring and the (R)-configuration of the core scaffold. Further evaluation of the representative compound 5 showed its inhibitory effect on HIF-1α protein accumulation and target gene expression under hypoxia.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21481991     DOI: 10.1016/j.ejmech.2011.03.022

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

Review 1.  Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.

Authors:  Elise Belaidi; Jessica Morand; Emmanuelle Gras; Jean-Louis Pépin; Diane Godin-Ribuot
Journal:  Pharmacol Ther       Date:  2016-08-02       Impact factor: 12.310

2.  AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis.

Authors:  Dae Gyu Kim; Yongseok Choi; Yuno Lee; Semi Lim; Jiwon Kong; JaeHa Song; Younah Roh; Dipesh S Harmalkar; Kwanshik Lee; Ja-Il Goo; Hye Young Cho; Ameeq Ul Mushtaq; Jihye Lee; Song Hwa Park; Doyeun Kim; Byung Soh Min; Kang Young Lee; Young Ho Jeon; Sunkyung Lee; Kyeong Lee; Sunghoon Kim
Journal:  Nat Commun       Date:  2022-05-11       Impact factor: 17.694

Review 3.  Action Sites and Clinical Application of HIF-1α Inhibitors.

Authors:  Renfeng Xu; Fan Wang; Hongqin Yang; Zhengchao Wang
Journal:  Molecules       Date:  2022-05-26       Impact factor: 4.927

4.  Mechanism of the natural product moracin-O derived MO-460 and its targeting protein hnRNPA2B1 on HIF-1α inhibition.

Authors:  Nak-Kyun Soung; Hye-Min Kim; Yukihiro Asami; Dong Hyun Kim; Yangrae Cho; Ravi Naik; Yerin Jang; Kusic Jang; Ho Jin Han; Srinivas Rao Ganipisetti; Hyunjoo Cha-Molstad; Joonsung Hwang; Kyung Ho Lee; Sung-Kyun Ko; Jae-Hyuk Jang; In-Ja Ryoo; Yong Tae Kwon; Kyung Sang Lee; Hiroyuki Osada; Kyeong Lee; Bo Yeon Kim; Jong Seog Ahn
Journal:  Exp Mol Med       Date:  2019-02-12       Impact factor: 8.718

Review 5.  Transition Metal Catalyzed Hiyama Cross-Coupling: Recent Methodology Developments and Synthetic Applications.

Authors:  Rida Noor; Ameer Fawad Zahoor; Muhammad Irfan; Syed Makhdoom Hussain; Sajjad Ahmad; Ali Irfan; Katarzyna Kotwica-Mojzych; Mariusz Mojzych
Journal:  Molecules       Date:  2022-09-02       Impact factor: 4.927

6.  Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancer.

Authors:  Wagdy M Eldehna; Rofaida Salem; Zainab M Elsayed; Tarfah Al-Warhi; Hamada R Knany; Rezk R Ayyad; Thamer Bin Traiki; Maha-Hamadien Abdulla; Rehan Ahmad; Hatem A Abdel-Aziz; Radwan El-Haggar
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

7.  Anti‑inflammatory compounds moracin O and P from Morus alba Linn. (Sohakuhi) target the NF‑κB pathway.

Authors:  Besse Hardianti; Lin Umeyama; Feng Li; Satoru Yokoyama; Yoshihiro Hayakawa
Journal:  Mol Med Rep       Date:  2020-10-20       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.